How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

U-um... this article will be handled by Mikuku. This time, I will organize the `miku-xlsx2md` tool I developed, focusing on a reference style. I... um, I'll do my ...

Esolangs - Programming languages designed for experimentation or as jokes rather than actual use. VBA - An event-driven version of Visual Basic 6.0 built into most Microsoft Office apps for automation ...